In last trading session, BioAtla Inc (NASDAQ:BCAB) saw 0.49 million shares changing hands with its beta currently measuring 1.06. Company’s recent per share price level of $3.13 trading at -$0.22 or -6.57% at ring of the bell on the day assigns it a market valuation of $150.55M. That closing price of BCAB’s stock is at a discount of -30.03% from its 52-week high price of $4.07 and is indicating a premium of 60.38% from its 52-week low price of $1.24. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.82 million shares which gives us an average trading volume of 517.68K if we extend that period to 3-months.
BioAtla Inc (NASDAQ:BCAB) trade information
Upright in the red during last session for losing -6.57%, in the last five days BCAB remained trading in the red while hitting it’s week-highest on Monday, 04/08/24 when the stock touched $3.13 price level, adding 21.16% to its value on the day. BioAtla Inc’s shares saw a change of 27.24% in year-to-date performance and have moved -17.63% in past 5-day. BioAtla Inc (NASDAQ:BCAB) showed a performance of 22.50% in past 30-days. Number of shares sold short was 5.59 million shares which calculate 11.56 days to cover the short interests.
BioAtla Inc (BCAB) estimates and forecasts
Statistics highlight that BioAtla Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 71.04% of value to its shares in past 6 months, showing an annual growth rate of 25.19% while that of industry is 13.30. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to decrease by -25.40% in the current quarter and calculating 6.90% increase in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -25.30% during past 5 years.
BCAB Dividends
BioAtla Inc is more likely to be releasing its next quarterly report in May and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
BioAtla Inc (NASDAQ:BCAB)’s Major holders
Insiders are in possession of 9.68% of company’s total shares while institution are holding 64.77 percent of that, with stock having share float percentage of 71.71%. Investors also watch the number of corporate investors in a company very closely, which is 64.77% institutions for BioAtla Inc that are currently holding shares of the company. Soleus Capital Management, L.P. is the top institutional holder at BCAB for having 4.32 million shares of worth $12.96 million. And as of Jun 29, 2023, it was holding 9.04% of the company’s outstanding shares.
The second largest institutional holder is Tang Capital Management, LLC, which was holding about 3.67 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 7.69% of outstanding shares, having a total worth of $11.02 million.
On the other hand, Vanguard Total Stock Market Index Fund and Wasatch Ultra Growth Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 1.3 million shares of worth $3.91 million or 2.73% of the total outstanding shares. The later fund manager was in possession of 1.1 million shares on Jun 29, 2023, making its stake of worth around $3.31 million in the company or a holder of 2.31% of company’s stock.
